###begin article-title 0
Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment
###end article-title 0
###begin p 1
Conceived and designed the experiments: MR. Performed the experiments: XZ CO. Analyzed the data: XZ CO RH MAM MR. Contributed reagents/materials/analysis tools: RH. Wrote the paper: MR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 301 308 301 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 327 334 327 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 327 334 327 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 388 395 388 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 388 395 388 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 403 410 403 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 489 496 489 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 504 511 504 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 504 511 504 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
t(9;22) is a balanced translocation, and the chromosome 22 breakpoints (Philadelphia chromosome - Ph+) determine formation of different fusion genes that are associated with either Ph+ acute lymphatic leukemia (Ph+ ALL) or chronic myeloid leukemia (CML). The "minor" breakpoint in Ph+ ALL encodes p185BCR/ABL from der22 and p96ABL/BCR from der9. The "major" breakpoint in CML encodes p210BCR/ABL and p40ABL/BCR. Herein, we investigated the leukemogenic potential of the der9-associated p96ABL/BCR and p40ABL/BCR fusion proteins and their roles in the lineage commitment of hematopoietic stem cells in comparison to BCR/ABL.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 60 66 <span type="species:ncbi:10090">murine</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
All t(9;22) derived proteins were retrovirally expressed in murine hematopoietic stem cells (SL cells) and human umbilical cord blood cells (UCBC). Stem cell potential was determined by replating efficiency, colony forming - spleen and competitive repopulating assays. The leukemic potential of the ABL/BCR fusion proteins was assessed by in a transduction/transplantation model. Effects on the lineage commitment and differentiation were investigated by culturing the cells under conditions driving either myeloid or lymphoid commitment. Expression of key factors of the B-cell differentiation and components of the preB-cell receptor were determined by qRT-PCR.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 8 15 8 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 23 30 23 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 291 298 291 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 291 298 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 324 331 324 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 324 331 324 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
Both p96ABL/BCR and p40ABL/BCR increased proliferation of early progenitors and the short term stem cell capacity of SL-cells and exhibited own leukemogenic potential. Interestingly, BCR/ABL gave origin exclusively to a myeloid phenotype independently from the culture conditions whereas p96ABL/BCR and to a minor extent p40ABL/BCR forced the B-cell commitment of SL-cells and UCBC.
###end p 7
###begin title 8
Conclusions/Significance
###end title 8
###begin p 9
Our here presented data establish the reciprocal ABL/BCR fusion proteins as second oncogenes encoded by the t(9;22) in addition to BCR/ABL and suggest that ABL/BCR contribute to the determination of the leukemic phenotype through their influence on the lineage commitment.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Faderl1">[1]</xref>
###xml 472 475 472 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Radich1">[3]</xref>
###xml 589 592 589 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Faderl1">[1]</xref>
###xml 609 610 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 794 795 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 836 839 836 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Gkbuget1">[4]</xref>
###xml 946 947 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 768 776 <span type="species:ncbi:9606">Patients</span>
t(9;22)(q34;q11) is detected in 95% of chronic myeloid leukemia (CML) cases as well as in 20-30% of adult acute lymphatic leukemia (ALL) cases. CML is a myeloproliferative syndrome characterized by an indolent chronic phase (CP) with an overgrowing mature myeloid cell population, which is, if not treated, inevitably followed by an acute phase, the so-called blast crisis (BC). Clinically, BC resembles acute leukemia, with a poor prognosis and resistance to therapy [1]-[3]. CML-BC displays a myeloid phenotype in two-thirds of cases and a lymphatic phenotype in the remaining one-third [1]. In contrast, Ph+-ALL is an acute disease from onset and is characterized by blasts that are blocked, in the majority of cases, at the pre-lymphatic stage of differentiation. Patients suffering from Ph+ ALL constitute a high risk group of ALL [4]. The factors that determine the evolution of CML, as well as the biological differences between CML and Ph+-ALL, are almost completely unknown.
###end p 11
###begin p 12
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcr</italic>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcr</italic>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">abl</italic>
###xml 619 626 619 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Faderl1">[1]</xref>
###xml 668 669 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 686 693 686 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 686 693 686 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 768 771 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Faderl1">[1]</xref>
###xml 793 800 793 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 793 800 793 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 879 880 879 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 885 888 885 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Barnes1">[5]</xref>
###xml 894 901 894 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">abl/bcr</italic>
###xml 1011 1018 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">abl/bcr</italic>
###xml 1120 1123 1120 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Melo2">[6]</xref>
###xml 1210 1217 1210 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1210 1217 1210 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1348 1351 1348 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Melo3">[7]</xref>
###xml 1437 1444 1437 1444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1437 1444 1437 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1092 1100 <span type="species:ncbi:9606">patients</span>
###xml 1320 1328 <span type="species:ncbi:9606">patients</span>
t(9;22) is usually a reciprocal translocation. A portion of chromosome 9 fuses to chromosome 22 (der22), thereby replacing a fragment of chromosome 22, which in turn fuses to chromosome 9 (der9). The cytogenetic correlate of der22 is the so-called Philadelphia chromosome (Ph). On chromosome 22, t(9;22) involves the bcr (breakpoint cluster region) gene locus. Two principal breaks occur: the (major) M-bcr, between exons 12 and 16, and the (minor) m-bcr, in the first intron of bcr. The breakpoint on chromosome 9 is consistently located in intron 1 of the abl gene locus. On der22, M-bcr leads to the creation of p210BCR/ABL, which is the hallmark of CML [1]. The Ph+ ALL-related p185BCR/ABL transcript is constant because the m-bcr breakpoint maps within an intron [1]. Although m-BCR (p185BCR/ABL-positive) is sporadically found in CML, it is considered to be specific for Ph+ ALL [5]. The abl/bcr fusion genes on der9 mainly differ in the specific breakpoint on chromosome 22. M-bcr results in the "small" abl/bcr, which encodes a "small" ABL/BCR transcript that is detectable in 65% of patients suffering from CML [6]. The resulting ABL/BCR fusion protein has a theoretical molecular mass of 40 kDa - p40ABL/BCR. The fusion between m-bcr and abl leads to a "large" transcript, which is present in 100% of examined patients with m-BCR Ph+ ALL [7]. This gene encodes a fusion protein with a theoretical molecular mass of 96 kDa - p96ABL/BCR.
###end p 12
###begin p 13
###xml 344 347 344 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Faderl1">[1]</xref>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Barnes2">[8]</xref>
###xml 467 470 467 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Kantarjian1">[9]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Tokarski1">[10]</xref>
The BCR/ABL fusion proteins are mutant ABL kinases. In normal cells, ABL kinase activity is finely regulated in response to growth factors and other stimuli. Through fusion to BCR, ABL becomes constitutively activated. This leads to constitutive activation of "down-stream" signal transduction pathways, including Ras, Jak/Stat and PI-3 kinase [1], [8]. The suppression of constitutively active ABL kinase with specific kinase inhibitors, such as Imatinib, Nilotinib [9] and Dasatinib [10], reverts the oncogenic potential of BCR/ABL.
###end p 13
###begin p 14
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Zheng1">[11]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Radziwill1">[12]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Radziwill1">[12]</xref>
###xml 618 622 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Ress1">[13]</xref>
###xml 795 799 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Zheng1">[11]</xref>
###xml 801 805 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Aelst1">[14]</xref>
The ABL/BCR fusion proteins are BCR mutants [11]. It has recently been reported that BCR is a negative regulator of proliferation and oncogenic transformation [12]. It associates with AF6 and Ras to form a trimeric complex, which is involved in the down-regulation of Ras-mediated signaling at sites of cell-cell contact to maintain cells in a non-proliferating state. The binding site for AF6 is located at the C-terminus of BCR [12]. Furthermore, BCR inhibits Wnt signaling by blocking Tcf-1/beta-catenin-mediated transcription. It disrupts the Tcf-1/beta-catenin complex by direct binding to beta-catenin and Tcf-1 [13]. Through its Rho-GEF and Rac-GAP functions, BCR plays an important role in cytoskeleton modeling by regulating the activity of Rho-like GTPases, such as Rac, cdc42 and Rho [11], [14].
###end p 14
###begin p 15
###xml 45 52 45 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 60 67 60 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Zheng1">[11]</xref>
###xml 289 296 289 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 289 296 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 373 380 373 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 382 391 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g001">Figure 1A</xref>
###xml 420 427 420 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 420 427 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Whitehead1">[15]</xref>
Very little is known about the biology of p40ABL/BCR and p96ABL/BCR and their roles in leukemogenesis. In both ABL/BCRs, fundamental functional features of wt BCR, including regulation of small Rho-like GTPases, are lost with negative consequences on cell motility [11]. CML-associated p40ABL/BCR lacks the oncogenic DH/PH domains that are conserved in the ALL-specific p96ABL/BCR (Figure 1A). Thus, the ALL-specific p96ABL/BCR fusion protein is an N-terminally truncated Rho-GEF and, therefore, a putative oncogene [15].
###end p 15
###begin title 16
The t(9;22) fusion proteins and their expression in Ph+ cells.
###end title 16
###begin p 17
###xml 1221 1228 1221 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1221 1228 1221 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1287 1294 1287 1294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1287 1294 1287 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 856 863 <span type="species:ncbi:9606">patient</span>
###xml 929 936 <span type="species:ncbi:9606">patient</span>
###xml 1009 1016 <span type="species:ncbi:9606">patient</span>
###xml 1118 1126 <span type="species:ncbi:9606">patients</span>
###xml 1171 1179 <span type="species:ncbi:9606">patients</span>
###xml 1206 1213 <span type="species:ncbi:9606">patient</span>
###xml 1272 1279 <span type="species:ncbi:9606">patient</span>
(A) Modular organization of the translocation partners and the fusion proteins in t(9;22). A schematic representation of the fusion proteins encoded by derivative 9 (der9) and 22 (der22), the Philadelphia chromosome, as well as of their combination in m-BCR-positive Ph+ ALL and M-BCR-positive CML, respectively. CC - coiled coil oligomerization interface; Y177 - Tyrosine phosphorylation site at aa 177; S/T kinase - serine/threonine kinase domain; DH - dbl homology domain; PH - pleckstrin homology domain; GAP - Rac-GAP domain; STEV - PDZ-domain binding motif; SH2 and SH3 - Src homology domains 2 and 3; Y kinase - tyrosine kinase domain; AB - actin binding domain. (B) Expression of the reciprocal ABL/BCR fusion proteins in Ph+ leukemia cell lines. Negative control: Phoenix cells; Tom-1, SD-1 and SupB15 - cell lines derived from m-BCR-positive ALL patient samples; BV173 - cells derived from a sample obtained from a CML patient in lymphatic BC; K562 - cells derived from a sample obtained from a CML patient in myeloid BC. (C) Expression of the reciprocal ABL/BCR fusion proteins in samples from Ph+ leukemia patients. Negative controls - three samples from AML patients and one sample from a CML patient for p96ABL/BCR in Ph+ ALL samples; one sample from an AML patient for p40ABL/BCR in CML samples.
###end p 17
###begin p 18
Herein, we investigated the leukemogenic potential of the ABL/BCR proteins, as well as their influence on the lineage commitment of early hematopoietic stem cells.
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
###xml 42 49 42 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 57 64 57 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 82 89 <span type="species:ncbi:9606">patient</span>
The reciprocal t(9;22) fusion proteins p40ABL/BCR and p96ABL/BCR are expressed in patient-derived Ph+ ALL and CML cells
###end title 20
###begin p 21
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 429 438 429 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g001">Figure 1A</xref>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
The fact that all m-BCR-positive Ph+ ALL and about two-thirds of M-BCR-positive CML patients express the reciprocal fusion transcript strongly suggests a fundamental role of the reciprocal ABL/BCR fusion gene in induction of the leukemogenic phenotype. The modular organization of the translocation partners and the resulting fusion proteins from m-BCR and M-BCR in t(9;22), which are present in Ph+ ALL and CML, is presented in Figure 1A.
###end p 21
###begin p 22
###xml 123 130 123 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 138 145 138 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 403 410 403 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 562 569 562 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 666 675 666 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g001">Figure 1B</xref>
###xml 683 684 683 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 710 711 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 984 991 984 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 984 991 984 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 993 1002 993 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g001">Figure 1B</xref>
###xml 213 220 <span type="species:ncbi:9606">patient</span>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
###xml 604 612 <span type="species:ncbi:9606">patients</span>
###xml 716 724 <span type="species:ncbi:9606">patients</span>
###xml 928 936 <span type="species:ncbi:9606">patients</span>
To confirm that the ABL/BCR transcript is translated into a functional protein, we first investigated the expression of p40ABL/BCR and p96ABL/BCR at the protein-level by Western blotting of extracts obtained from patient-derived Ph+-ALL and CML cells. We used SupB15, SD-1 and TOM-1 cells, as well as samples from 3 Ph+ ALL patients, all known to present m-BCR and expected to express the reciprocal p96ABL/BCR. The CML-blast crisis-derived BV173 and K562 cells and samples from 6 CML patients harboring the M-BCR, and thus expected to express the reciprocal p40ABL/BCR, were also included. Samples from patients with AML were used as negative controls. As shown in Figure 1B, all Ph+ ALL cell lines and 3/3 Ph+ ALL patients exhibited a band of about 96 kDa, which was absent in the CML-derived cell lines and in the negative controls. In contrast, a band of about 40 kDa was detected in only the lymphatic BV173 and in 3/6 CML patients. The myeloid K562 cells did not express the p40ABL/BCR (Figure 1B).
###end p 22
###begin p 23
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 290 297 290 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 290 297 290 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 156 163 <span type="species:ncbi:9606">patient</span>
Taken together, these data show that the reciprocal ABL/BCR proteins were expressed not only at the transcriptional level, but also at the protein level in patient-derived cells. It is noteworthy that, in contrast to CML, all tested m-BCR-positive Ph+ ALL cells expressed the reciprocal p96ABL/BCR, suggesting a putative role for this fusion protein in induction of the leukemic phenotype.
###end p 23
###begin title 24
###xml 8 15 8 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 23 30 23 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 44 51 44 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 90 96 <span type="species:ncbi:10090">murine</span>
Both p40ABL/BCR and p96ABL/BCR, but not p185BCR/ABL, increase the replating efficiency of murine HSCs and block their myeloid differentiation
###end title 24
###begin p 25
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 157 164 157 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 199 207 199 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 336 343 336 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 348 355 348 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 363 370 363 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 363 370 363 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 432 436 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Zheng2">[16]</xref>
###xml 437 446 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2A</xref>
###xml 544 553 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2B</xref>
###xml 679 688 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2C</xref>
###xml 712 719 708 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 712 719 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 727 734 723 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 727 734 723 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 869 878 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2C</xref>
###xml 1020 1024 1016 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Lavau1">[17]</xref>
###xml 1026 1030 1022 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Johnson1">[18]</xref>
###xml 1044 1053 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2D</xref>
###xml 1072 1079 1068 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1072 1079 1068 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1168 1175 1164 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1168 1175 1164 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1204 1211 1200 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1204 1211 1200 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1418 1425 1410 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1418 1425 1410 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1528 1537 1520 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2D</xref>
###xml 1569 1576 1561 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1569 1576 1561 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1585 1592 1577 1584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1585 1592 1577 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1759 1766 1751 1758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1759 1766 1751 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1810 1819 1802 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2E</xref>
Both CML and Ph+ ALL have been proposed to originate from a transformed stem cell. Therefore, we compared the effects of the ABL/BCR fusion proteins and p185BCR/ABL on the biology of HSC. First, the in vitro replating efficiency in semi-solid medium in the presence of hematopoietic growth factors of Sca1+/lin- HSCs transduced with p40ABL/BCR, p96ABL/BCR or p185BCR/ABL was determined. gamma-catenin was used as a positive control [16](Figure 2A). Transgene expression was controlled in the colony forming units (CFUs) from the first plating (Figure 2B). Here, we show that the replating efficiency of the empty-vector transduced controls was limited to one cycle of replating (Figure 2C). In contrast, both p40ABL/BCR and p96ABL/BCR increased the replating efficiency over four cycles, with a maintenance or increase in the number of CFUs in each round of replating (Figure 2C). The morphologies of the colonies were classified as type A, B or C colonies according to the descriptions provided by Lavau and co-workers [17], [18]. As shown in Figure 2D, expression of p96ABL/BCR led to type A colonies, which are typical compact colonies, representing >90% of the p96ABL/BCR-positive colonies. Also, p40ABL/BCR gave rise to more than 80% type A colonies. In contrast, gamma-catenin CFU colonies were mainly of type B, with a dense center surrounded by a halo of migrating cells, whereas empty-vector controls and p185BCR/ABL-positive cells exhibited the type C morphology of diffuse colonies with mobile differentiating cells (Figure 2D). The immature character of p40ABL/BCR- and p96ABL/BCR-positive CFU was confirmed by the high expression levels of c-Kit and Sca1, and low levels of the myeloid differentiation markers Gr-1 and Mac-1 in comparison to p185BCR/ABL-positive CFU and mock-transduced controls (Figure 2E).
###end p 25
###begin title 26
###xml 56 62 <span type="species:ncbi:10090">murine</span>
Effect of the t(9;22) fusion proteins on the biology of murine HSCs.
###end title 26
###begin p 27
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 582 583 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 587 588 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 786 787 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 791 792 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1472 1473 1472 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1477 1478 1477 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1741 1748 1741 1748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1741 1748 1741 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1753 1760 1753 1760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1753 1760 1753 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1768 1775 1768 1775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1768 1775 1768 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 2213 2214 2209 2210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2218 2219 2214 2215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2347 2358 2343 2354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(cip1/waf1)</sup>
###xml 2531 2543 2527 2531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;/&#916;</sup>
###xml 102 108 <span type="species:ncbi:10090">murine</span>
(A) Experimental strategy for studying the influence of the t(9;22) fusion proteins on the biology of murine HSCs. Sca1+/lin- BM cells were infected with the indicated retroviruses and plated in semi-solid medium supplemented with the indicated growth factors for determination of the serial replating potential. Cells from the first plating (I) round were examined for the expression of differentiation-specific surface markers. Cells plated in liquid culture supplemented with the indicated growth factors were used for cell cycle analysis and gene expression by qRT-PCR. (B) Sca1+/lin- BM cells were infected with the indicated retroviruses and expression levels of the transgenes were analyzed by Western blotting using the indicated antibodies. (C) Long-term serial replating. Sca1+/lin- cells were infected with the indicated retroviruses and plated into methyl-cellulose supplemented with the indicated growth factors to assess primary colony formation. Colony numbers were counted on days 8-10. Cells were then harvested and serially replated. Colonies were counted on days 8-10 after each replating. (D) Colony morphology during the first plating. Type A (compact colonies), type B (dense center surrounded by a halo of migrating cells) and type C (diffuse colonies with mobile differentiating cells) colonies were distinguished. (E) Expression of differentiation-specific surface markers. One representative experiment of three yielding similar results. (F) Sca1+/lin- BM cells were infected with the indicated retroviruses and, after 48 h, cell cycle progression was determined. The provided results are the average of three independent experiments +/- SD. (G) Activation of Wnt-signaling by the t(9;22) fusion proteins. BCR, p185BCR/ABL, p40ABL/BCR and p96ABL/BCR and the Topflash and Fopflash reporter constructs were co-transfected by electroporation into U937 cells. U937 cells expressing PML/RARalpha - positive control; pGL3basic - negative control. Luciferase activity measured at 24 h post-transfection was normalized to Renilla luciferase activity. Each experiment was performed in triplicate a total of three times with similar results. One representative experiment is given +/- SD. (H) Sca1+/lin- BM cells were infected with the indicated retroviruses and, at 48 h post-infection, the expression levels of HoxB4, Cdkn1a (p21(cip1/waf1)), c-Myc and SCL were analyzed by qRT-PCR. The relative concentration of each mRNA was normalized to the concentration of the housekeeping gene GAPDH and is represented as 2-Delta/Delta CT. Each experiment was performed in triplicate a total of three times with similar results. One representative experiment is given +/- SD.
###end p 27
###begin p 28
###xml 191 200 191 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2A</xref>
###xml 215 224 215 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2F</xref>
###xml 244 251 244 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 244 251 244 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 348 355 348 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 362 369 362 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 362 369 362 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 420 421 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 87 93 <span type="species:ncbi:10090">murine</span>
To study the influence of the t(9;22) fusion proteins on the cell cycle progression of murine HSC, we maintained the transduced cells in liquid culture for 48 h prior to cell cycle analysis (Figure 2A). As shown in Figure 2F, expression of p185BCR/ABL did not lead to an increase in the percent of cells in S phase, whereas expression of either p40ABL/BCR or p96ABL/BCR led to a reduction in the percent of cells in G0/G1 phase with a proportional increase in the amount of cells in the S phase, as compared to the controls.
###end p 28
###begin p 29
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Orkin1">[19]</xref>
###xml 439 446 439 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 439 446 439 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 451 458 451 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 451 458 451 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 465 472 465 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 465 472 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 610 617 606 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 610 617 606 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 625 632 621 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 625 632 621 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 694 701 690 697 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 694 701 690 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 786 795 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2G</xref>
###xml 852 861 844 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1/Waf1</sup>
###xml 885 886 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 890 891 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 912 919 904 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 912 919 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 924 931 916 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 924 931 916 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 938 945 930 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 938 945 930 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 987 996 979 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g002">Figure 2H</xref>
###xml 1028 1035 1020 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1028 1035 1020 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1045 1052 1037 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1045 1052 1037 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1060 1067 1052 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1060 1067 1052 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1120 1127 1112 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1120 1127 1112 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1140 1147 1132 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1140 1147 1132 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1153 1160 1145 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1153 1160 1145 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1260 1267 1252 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1260 1267 1252 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1275 1282 1267 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1275 1282 1267 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1295 1302 1287 1294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1295 1302 1287 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
To explain these different effects on the biology of early HSC, we investigated how the t(9;22) fusion proteins interfere with the regulators of "stemness", such as Wnt-signaling, c-Myc, HoxB4, Cdkn1a, Bmi-1 and SCL [19]. More specifically, we investigated the effect of the ABL/BCRs on Wnt-signaling by measuring Tcf/Lef transcriptional activity through determination Topflash/Fopflash reporter activity in U937 cells expressing BCR, p185BCR/ABL, p40ABL/BCR or p96ABL/BCR. U937 cells expressing PML/RARalpha, which is known to activate Wnt signaling, were used as a positive control. In these cells, BCR, p185BCR/ABL and p40ABL/BCR had no effect on Tcf/Lef-dependent transcription, whereas p96ABL/BCR activated Tcf/Lef-dependent transcription to a larger extent than did PML/RARalpha (Figure 2G). Next, we assessed the expression of HoxB4, Cdkn1a (p21Cip1/Waf1), c-Myc and SCL in Sca1+/lin- HSCs expressing p185BCR/ABL, p40ABL/BCR or p96ABL/BCR by quantitative real time PCR (qRT-PCR). Figure 2H shows that, in contrast to p185BCR/ABL, both p40ABL/BCR and p96ABL/BCR induced the transcription of HoxB4. Conversely, p185BCR/ABL, but not p40ABL/BCR or 96ABL/BCR, up-regulated Cdkn1a expression. All of the fusion proteins down-regulated c-Myc, whereas only p185BCR/ABL and p40ABL/BCR, but not p96ABL/BCR, down-regulated SCL expression. Bmi-1 was not influenced by the t(9;22) fusion proteins (data not shown).
###end p 29
###begin p 30
###xml 145 152 145 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 223 230 223 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 282 289 282 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
These findings indicate that all of the fusion proteins regulated the expression of genes involved in the maintenance of stem cell capacity; p185BCR/ABL up-regulated Cdkn1a and down-regulated c-Myc (Wilson et al. 2004), p40ABL/BCR up-regulated HoxB4 and down-regulated c-Myc and p96ABL/BCR activated Wnt-signaling, up-regulated HoxB4 and down-regulated c-Myc.
###end p 30
###begin title 31
###xml 80 86 <span type="species:ncbi:10090">murine</span>
All t(9;22)-associated fusion proteins increased the re-population potential of murine HSCs
###end title 31
###begin p 32
###xml 34 41 34 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 46 53 46 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 62 69 62 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 62 69 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 196 203 196 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 208 215 208 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 224 231 224 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 224 231 224 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 315 316 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 476 485 476 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g003">Figure 3A</xref>
###xml 582 589 582 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 582 589 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 591 600 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g003">Figure 3B</xref>
###xml 619 626 619 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
To investigate whether and how p40ABL/BCR, p96ABL/BCR and p185BCR/ABL influence stem cell capacity, we performed a competitive repopulating assay (CRA). CD45.1+/Sca1+/lin- HSCs transduced with p40ABL/BCR, p96ABL/BCR and p185BCR/ABL were inoculated together with CD45.2+ HSCs into lethally irradiated congenic CD45.2+ recipient mice. Chimerism was measured after 12 weeks in order to determine the re-population capacity of these cells as an index of their stem cell capacity (Figure 3A). Both ABL/BCR fusion proteins increased re-population; this effect was most pronounced with p96ABL/BCR (Figure 3B). Remarkably, p185BCR/ABL also conferred increased engraftment, although it did not increase serial replating efficiency, as shown above. Finally, at short time points after transplantation, the levels of chimerism in the peripheral blood were equivalent, suggesting that the observed effects were unlikely to be a consequence of differences in homing (data not shown).
###end p 32
###begin title 33
###xml 71 77 <span type="species:ncbi:10090">murine</span>
Effect of the t(9;22) fusion proteins on the re-population capacity of murine HSC.
###end title 33
###begin p 34
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 366 367 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 107 113 <span type="species:ncbi:10090">murine</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
(A) The schematic indicates the experimental procedure for determination of the re-population potential of murine HSCs expressing t(9;22) fusion proteins. Sca1+/lin- BM cells from CD45.1+ mice were infected with the indicated retroviruses and, at 48 h post-infection, the cells were transplanted together with CD45.2+ BM cells into lethally (11 Gy) irradiated CD45.2+ recipient mice. Analysis of donor chimerism was performed 12 weeks after transplantation. (B) Plots show representative donor-derived chimerisms from individual mice at 12 weeks post-transplantation. (C) Graph of donor-derived chimerism in each mouse after long-term reconstitution (4-5 mice/group).
###end p 34
###begin p 35
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Taken together, these data indicate that all t(9;22)-associated fusion proteins are able to increase stem cell re-population of Sca1+/lin- HSCs.
###end p 35
###begin title 36
###xml 8 15 8 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 23 30 23 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
Both p40ABL/BCR and p96ABL/BCR have leukemogenic potential
###end title 36
###begin p 37
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Puccetti1">[20]</xref>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 329 336 329 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 341 348 341 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 526 527 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 531 532 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 539 548 535 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g004">Figure 4A</xref>
###xml 654 661 646 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 654 661 646 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 716 725 708 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g004">Figure 4B</xref>
###xml 765 772 757 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 765 772 757 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 889 898 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g004">Figure 4B</xref>
###xml 925 932 917 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 925 932 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 940 947 932 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 940 947 932 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1071 1075 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Kogan1">[21]</xref>
###xml 1076 1087 1068 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g004">Figure 4C&#8211;E</xref>
###xml 1155 1156 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 298 304 <span type="species:ncbi:10090">murine</span>
###xml 551 555 <span type="species:ncbi:10090">Mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 1114 1118 <span type="species:ncbi:10090">mice</span>
The fact that the ABL/BCRs induce a leukemic phenotype in HSC, which is characterized by a block of myeloid differentiation and increased stem cell capacity similar to that of other leukemia-associated fusion proteins [20], prompted us to investigate their leukemogenic potential. Thus, Sca1+/lin- murine HSCs transduced with p40ABL/BCR, p96ABL/BCR and gamma-catenin (positive control) were inoculated into sub-lethally (8 Gy) irradiated recipients. As controls, we used recipients inoculated with empty-vector transduced Sca1+/lin- HSCs (Figure 4A). Mice inoculated with control gamma-catenin-transduced cells became sick within 16-245 days, whereas p40ABL/BCR induced disease within 26-373 days after inoculation (Figure 4B). In contrast, mice inoculated with p96ABL/BCR-transduced cells showed a delay in the onset of disease (241-412 days). Penetrance for all transgenes was relevant (Figure 4B). The presence of both p40ABL/BCR and p96ABL/BCR induced a myeloid leukemia-like phenotype with maturation, associated with moderate splenomegaly (0.2-0.6 mg spleen weight)[21](Figure 4C-E). The WBC in the leukemic mice at diagnosis ranged from 15 to 34x103 cells/microL (data not shown).
###end p 37
###begin title 38
###xml 33 40 33 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 48 55 48 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
The leukemogenic potential of p40ABL/BCR and p96ABL/BCR.
###end title 38
###begin p 39
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 611 618 607 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 611 618 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 624 631 620 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 624 631 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
(A) Experimental strategy to model leukemia induced by the reciprocal t(9;22) fusion proteins. Sca1+/lin- BM cells were infected with the indicated retroviruses and inoculated into sub-lethally irradiated mice. As positive and negative controls, we used gamma-catenin and empty vector-transduced cells, respectively. (B) Survival curves show the frequency of recipients succumbing to disease after receiving the transduced cells. Statistical relevance was set at p<0.05. (C) May-Grunwald-Giemsa staining of cytospins from BM and spleen of one representative mouse in each group. (D) Relative splenomegaly of p40ABL/BCR-, p96ABL/BCR- or gamma-catenin-positive leukemia. (E) Expression of differentiation-specific surface markers.
###end p 39
###begin p 40
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Taken together, these data show that both ABL/BCR fusion proteins are able to induce a leukemic phenotype in vivo.
###end p 40
###begin title 41
###xml 19 26 19 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 31 38 31 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
In contrast to p185BCR/ABL, p96ABL/BCR increases the serial replating potential of early stem cell derived B-lymphatic progenitors
###end title 41
###begin p 42
###xml 4 11 4 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 19 26 19 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 291 284 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 478 479 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 504 511 504 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 504 511 504 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 516 523 516 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 516 523 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 531 538 531 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 531 538 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5A</xref>
###xml 691 700 691 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5B</xref>
###xml 719 726 719 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 719 726 719 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 830 837 830 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 830 837 830 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 974 983 974 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5B</xref>
p185BCR/ABL and p96ABL/BCR are constantly and exclusively co-expressed in m-BCR-positive Ph+ ALL, which exhibits an immature phenotype blocked at an antigen-independent stage of differentiation. This prompted us to compare the effects of the ABL/BCR fusion proteins with those of p185BCR/ABL on the biology of HSC-derived B cell progenitors in vitro. Thus, the in vitro replating efficiency in semi-solid medium in the presence of SCF, Flt3 ligand (Flt3-L) and IL-7 of Sca1+/lin- HSCs transduced with p40ABL/BCR, p96ABL/BCR or p185BCR/ABL was determined (Figure 5A). Here, we show that the replating efficiency of the empty-vector-transduced controls was limited to two cycles of replating (Figure 5B). In contrast, p96ABL/BCR increased the replating efficiency by over five cycles and also led to an increased number of CFUs. p40ABL/BCR augmented the number of CFUs, but not the replating efficiency as compared to the control cells, indicating an effect on proliferation (Figure 5B).
###end p 42
###begin title 43
###xml 27 34 27 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 39 46 39 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 55 62 55 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 91 97 <span type="species:ncbi:10090">murine</span>
Differential effects of p40ABL/BCR, p96ABL/BCR and p185BCR/ABL on the B cell commitment of murine HSCs.
###end title 43
###begin p 44
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 569 570 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1226 1233 1226 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1226 1233 1226 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1362 1363 1362 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 123 129 <span type="species:ncbi:10090">murine</span>
(A) Experimental strategy for studying the influence of the reciprocal t(9;22) fusion proteins on the B cell commitment of murine HSCs. Sca1+/lin- BM cells were infected with the indicated retroviruses and plated in semi-solid medium supplemented with the indicated growth factors for determination of the serial replating potential. Cells from the first plating (I) round and cells plated in liquid culture supplemented with the indicated growth factors were examined for the expression of differentiation-specific surface markers. (B) Long-term serial replating. Sca1+/lin- cells were infected with the indicated retroviruses and plated into methyl-cellulose medium supplemented with the indicated growth factors to assess primary colony formation. Colony numbers were counted on days 8-10. Cells were then harvested and serially replated. Colonies were counted on days 8-10 for each replating. I-IV - number of the plating round. (C) Expression of differentiation-specific surface markers. (D) Colony morphology of the second plating. Type A (compact colonies), type B (a dense center surrounded by a halo of migrating cells) and type C (diffuse colonies with mobile differentiating cells) colonies were distinguished. p185BCR/ABL exhibited a high number of viable cells that were not organized into colonies. (E) Determination of the maturation stage of B220+ lymphocytes by CD43 expression analysis. CD43 positivity is characteristic of immature pro-B cells.
###end p 44
###begin p 45
###xml 12 19 12 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 28 35 28 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 198 207 198 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5C</xref>
###xml 231 238 231 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 366 375 366 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5C</xref>
Both the p40ABL/BCR- and p96ABL/BCR-positive colonies exhibited a lymphatic phenotype as revealed by strong positivity for the B220 surface marker and absence of the Mac-1 marker for myeloid cells (Figure 5C). In contrast, the p185BCR/ABL-positive colonies were nearly completely negative for B220 and exhibited a myeloid phenotype as shown by positivity for Mac-1 (Figure 5C).
###end p 45
###begin p 46
###xml 123 132 123 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5D</xref>
###xml 155 162 155 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 155 162 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 206 213 206 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 383 390 383 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 383 390 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5D</xref>
###xml 582 589 582 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 582 589 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 597 604 597 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 597 604 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 689 696 689 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 689 696 689 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 705 712 705 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 705 712 705 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 726 727 726 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 833 840 833 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 833 840 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 918 919 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1007 1016 1007 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g005">Figure 5E</xref>
The morphology of the colonies was classified as type A, B or C according to the myeloid CFUs described above. As shown in Figure 5D, the expression of p40ABL/BCR led to compact type A colonies, whereas p96ABL/BCR gave rise to type A (about 40%) and smaller, less compact type B colonies (about 60%). Control cells exhibited the type B morphology with mobile cells. In contrast, p185BCR/ABL-positive cells did not exhibit colonies in the second plating round, but many viable cells were present that were apparently unable to give rise to colonies (Figure 5D). The expression of p40ABL/BCR and p96ABL/BCR induced a differentiation block as revealed by the fact that the majority of the p40ABL/BCR- and p96ABL/BCR-positive B220+ B cell population expressed CD43, a marker of the immature pro-B cell compartment. In contrast, most p185BCR/ABL-positive cells expressed the myeloid marker Mac-1, and the few lymphatic B220+ cells exhibited a more mature phenotype as revealed by the absence of CD43 expression (Figure 5E).
###end p 46
###begin p 47
###xml 105 112 105 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 230 237 230 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 269 276 269 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
Taken together, these data suggest that, upon receipt of signaling that drives lymphatic commitment, p185BCR/ABL exhibits an apparently "paradox" phenotype characterized by expression of the myeloid surface marker Mac-1, while p40ABL/BCR increases proliferation and p96ABL/BCR fully transforms early B cell progenitors.
###end p 47
###begin title 48
###xml 15 22 15 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 37 44 37 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 104 109 <span type="species:ncbi:9606">human</span>
BCR/ABL and p40ABL/BCR block, but p96ABL/BCR stimulates the generation of CD19+ B cell progenitors from human CD34+ UCBC
###end title 48
###begin p 49
###xml 148 155 148 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 160 167 160 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 175 182 175 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 273 280 273 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 273 280 273 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 289 296 289 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 289 296 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Feldhahn1">[22]</xref>
###xml 386 393 386 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 386 393 386 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 539 540 539 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 597 598 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Ohkawara1">[23]</xref>
###xml 720 721 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 771 778 771 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 771 778 771 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 783 790 783 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 783 790 783 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 797 804 797 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 878 887 878 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g006">Figure 6A</xref>
###xml 931 932 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 994 995 994 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1019 1020 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1041 1048 1041 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1054 1061 1054 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1054 1061 1054 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1069 1076 1069 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1069 1076 1069 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1125 1132 1125 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1125 1132 1125 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1148 1149 1148 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1157 1166 1157 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g006">Figure 6B</xref>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
###xml 529 534 <span type="species:ncbi:9606">human</span>
To exclude that the observed effects of the t(9;22) fusion proteins on B cell commitment were specific to murine HSC, we studied the effects of p185BCR/ABL, p96ABL/BCR and p40ABL/BCR on the generation of human B cell progenitors. Based on recent data showing that both p185BCR/ABL and p210BCR/ABL block B cell differentiation [22], we extended our experiments to the CML-associated p210BCR/ABL protein. To study early human B-lymphopoiesis, we used a co-culture system with a monolayer of the BM stroma cell line, MS-5, in which human CD34+ umbilical cord blood cells (UCBCs) differentiate to CD19+ cells within 3-5 weeks. The addition of SCF and G-CSF highly enhances the production of CD19+ cells [23]. Therefore, CD34+ UCBCs that were retrovirally transduced with p185BCR/ABL, p96ABL/BCR or p40ABL/BCR were co-cultured with MS5 stroma cells in the presence of SCF and G-CSF (Figure 6A). After three weeks, the percentage of CD19+ cells was determined. Herein, we show that the amount of CD19+ cells derived from CD34+ UCBCs expressing p40ABL/BCR, p185BCR/ABL or p210BCR/ABL was lower in comparison to that derived from p96ABL/BCR-expressing CD34+ UCBCs (Figure 6B).
###end p 49
###begin title 50
###xml 27 34 27 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 39 46 39 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 52 59 52 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 68 75 68 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Differential effects of p40ABL/BCR, p96ABL/BCR, p185BCR/ABL and p210BCR/ABL on the B cell commitment of human HSC.
###end title 50
###begin p 51
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 355 356 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 123 128 <span type="species:ncbi:9606">human</span>
(A) Experimental strategy for studying the influence of the reciprocal t(9;22) fusion proteins on the B cell commitment of human CD34+ UCBCs. CD34+ UCBCs were infected with the indicated retroviruses and plated on MS5 cells in the presence of SCF and G-CSF. After three weeks, the percentage of CD19+ cells was determined. (B) Histograms representing CD19+ cells in the GFP-positive cell population. The experiments were performed twice with similar results.
###end p 51
###begin p 52
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
In summary, these findings support our data on the influence of the t(9;22) fusion proteins on B cell commitment in the mouse.
###end p 52
###begin title 53
Opposite effects of BCR/ABL and ABL/BCR on key factors of lymphoid commitment and pre-B cell receptor signaling
###end title 53
###begin p 54
###xml 316 324 316 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 356 363 356 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 356 363 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 369 376 369 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 369 376 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 381 388 381 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 381 388 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 396 403 396 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 396 403 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 432 439 432 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 432 439 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 443 450 443 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 443 450 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 459 466 459 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 470 477 470 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 470 477 470 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 485 486 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 490 491 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 801 810 801 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g007">Figure 7A</xref>
###xml 1048 1057 1048 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g007">Figure 7B</xref>
###xml 1072 1081 1072 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g007">Figure 7C</xref>
###xml 1095 1102 1095 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1095 1102 1095 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1111 1118 1111 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1111 1118 1111 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1247 1254 1247 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1247 1254 1247 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1263 1270 1263 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1263 1270 1263 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1352 1359 1352 1359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1352 1359 1352 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1378 1385 1378 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1378 1385 1378 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1473 1480 1473 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1473 1480 1473 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1488 1495 1488 1495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1488 1495 1488 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
Our data suggest that BCR/ABL and ABL/BCR exert different effects on the B cell commitment of early HSCs. Because ABL/BCR proteins are expressed together with the BCR/ABL fusion proteins in leukemic cells, we studied the influence of their co-expression with BCR/ABL on the biology of HSC-derived B cell progenitors in vitro. We retrovirally expressed p185BCR/ABL, p210BCR/ABL, p40ABL/BCR and p96ABL/BCR and the combinations of p185BCR/ABL/p40ABL/BCR and p185BCR/ABL/p96ABL/BCR in Sca1+/lin- HSCs. These cells were plated either in semi-solid medium for the determination of their serial replating potential or in liquid culture for detection of the expression of key regulators of B cell differentiation; in both cases, the cells were cultured in the presence of SCF, Flt3-L and IL-7 as described in Figure 7A. The expression levels of the single transgenes did not differ between the cells that expressed the transgenes alone or in combination, suggesting that the observed effects were unlikely to be a consequence of differences in expression (Figure 7B). As shown in Figure 7C, neither p185BCR/ABL nor p210BCR/ABL increased the serial replating potential or the CFU number as compared to empty vector-transduced controls. Co-expression of p40ABL/BCR and p185BCR/ABL led to an increase in the CFU, indicating an effect on proliferation, whereas p96ABL/BCR together with p185BCR/ABL not only increased the CFU-number, but also the replating efficiency as compared to p40ABL/BCR and p96ABL/BCR alone. Taken together, these data suggest that the reciprocal t(9;22) fusion proteins cooperate in the determination of a leukemic phenotype for B cell progenitors.
###end p 54
###begin title 55
Influence of the t(9;22) fusion proteins alone or in combination on B cell commitment and expression of B cell-specific gene transcripts.
###end title 55
###begin p 56
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 377 378 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 502 503 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 960 961 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 965 966 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1262 1274 1262 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;/&#916;</sup>
###xml 123 129 <span type="species:ncbi:10090">murine</span>
(A) Experimental strategy for studying the influence of the reciprocal t(9;22) fusion proteins on the B cell commitment of murine HSCs. Sca1+/lin- BM cells were infected with the indicated retroviruses and plated in semi-solid medium supplemented with the indicated growth factors for determination of the serial replating potential. (B) Transgene expression in transduced Sca1+/lin- BM cells as determined by Western blotting using the indicated antibodies. (C) Long-term serial replating of Sca1+/lin- cells infected with the indicated retroviruses and plated into wells containing methyl-cellulose medium supplemented with the indicated growth factors to assess primary colony formation. Colony numbers were determined on days 8-10. Cells were harvested and replated for the determination of the serial replating potential (D-E). Influence of the t(9;22) fusion proteins on key factors involved in B cell commitment and the pre-B cell receptor complex. Sca1+/lin- BM cells were infected with the indicated retroviruses and, at 48 h post-infection, the expression of PAX5, E2A, ID2, BLNK, CD19 and CD79a were analyzed by qRT-PCR. The relative concentration of each mRNA was normalized to the concentration of the housekeeping gene GAPDH and is represented as 2-Delta/Delta CT. Each experiment was performed in triplicate a total of three times with similar results. One representative experiment is given +/- SD.
###end p 56
###begin p 57
###xml 39 46 39 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 54 61 54 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 103 110 103 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Cobaleda1">[24]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Hagman1">[25]</xref>
###xml 517 518 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 544 551 544 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 544 551 544 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 557 564 557 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 557 564 557 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 569 576 569 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 569 576 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 583 590 583 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 627 634 627 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 627 634 627 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 642 649 642 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 642 649 642 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 657 664 657 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 657 664 657 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 672 679 672 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 672 679 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 693 702 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g007">Figure 7D</xref>
###xml 818 825 818 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 818 825 818 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 833 840 833 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 833 840 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 941 948 941 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 941 948 941 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 953 960 953 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 953 960 953 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1053 1060 1053 1060 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1053 1060 1053 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1350 1354 1350 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Gonda1">[26]</xref>
###xml 1356 1360 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Mathas1">[27]</xref>
###xml 1385 1392 1385 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1385 1392 1385 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1401 1408 1401 1408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1401 1408 1401 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1569 1578 1569 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g007">Figure 7D</xref>
The different phenotypic effects of p40ABL/BCR and p96ABL/BCR and the apparent "paradox" effect of p185BCR/ABL on B cell development prompted us to investigate the influence of the t(9;22) fusion proteins on fundamental steps of B cell development: commitment and pre-B cell differentiation. Here, we studied the influence of the t(9;22) fusion proteins on E2A and PAX5, which are both indispensable for the commitment of stem cells to the B cell lineage [24], [25]. Their expression was determined by qRT-PCR in Sca1+/lin- HSCs expressing p185BCR/ABL, p210BCR/ABL, p40ABL/BCR or p96ABL/BCR, as well as those co-expressing p185BCR/ABL and p40ABL/BCR or p185BCR/ABL and p96ABL/BCR. As shown in Figure 7D, both BCR/ABL fusion proteins abolished the expression of PAX5 and strongly reduced that of E2A, in contrast to p40ABL/BCR and p96ABL/BCR, neither of which strongly impacted the expression of E2A or PAX5 alone. In cells co-expressing p185BCR/ABL, p40ABL/BCR almost completely reverted the abolition of PAX5, but not of E2A expression. Conversely, p96ABL/BCR only partially reverted the PAX5 suppression and nearly completely reverted the down-regulation of E2A. To understand how BCR/ABL regulates the expression of PAX5 and E2A, we determined the expression level of the transcription suppressor ID2, which is known to regulate both PAX5 and E2A [26], [27]. We found that both p185BCR/ABL and p210BCR/ABL up-regulated ID2, an effect that was nearly completely abolished by the ABL/BCRs, which did not have any effect on ID2 expression when expressed independently (Figure 7D).
###end p 57
###begin p 58
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Jumaa1">[28]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Fu1">[29]</xref>
###xml 586 595 582 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007661-g007">Figure 7E</xref>
###xml 701 708 697 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 701 708 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 728 735 724 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 728 735 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 929 936 925 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 929 936 925 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
The targeted disruption of structural components or down-stream signaling proteins of the pre-B cell-receptor complex results in the arrest of B cell development. Importantly, the expression and activity of proteins that are critical for pre-B cell receptor signaling are strictly regulated [28]. Therefore, we addressed the question of whether t(9;22) fusion proteins interfere with the expression of key components of the proximal pre-B cell signaling cascade, such as the adaptor protein BLNK (or SLP65)[29], the co-receptor CD19 and the signaling chain Igalpha (CD79a). As shown in Figure 7E, the BCR/ABLs abolished the expression of BLNK and CD79a and reduced that of CD19. The CML-associated p40ABL/BCR, in contrast to p96ABL/BCR, also reduced the expression of BLNK and CD79a, whereas neither of these proteins influenced the expression of CD19. It is noteworthy that both reverted, at least partially, the effects of p185BCR/ABL on the pre-B cell receptor complex components.
###end p 58
###begin p 59
Taken together, these data strongly suggest that the BCR/ABL fusion proteins inhibit signaling pathways that are indispensable for normal B cell development at an early stem cell stage, an effect that is partially reverted by the reciprocal ABL/BCR fusion proteins.
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 248 255 248 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 248 255 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Michor1">[30]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Era1">[31]</xref>
###xml 696 703 696 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 696 703 696 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 868 875 868 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 868 875 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 360 366 <span type="species:ncbi:10090">murine</span>
Until now, the biology of Ph+ leukemia has been strictly limited to der22-encoded BCR/ABL and the related signal transduction pathways. Only CML-CP, a myeloproliferative syndrome, can be explained by the biology of BCR/ABL alone. It seems that p210BCR/ABL is able to induce and maintain indolent CML-CP. In fact, mathematical analysis together with studies on murine embryonic stem cells strongly suggests that BCR/ABL alone is sufficient to induce CML-CP without the need for any additional mutations [30], [31]. Progression to acute blast crisis is associated with additional mutations that might be independent of reciprocal ABL/BCR fusion protein expression, as suggested by the fact that p40ABL/BCR is not uniformly present in CML. In contrast, it is unlikely that an acute leukemia such as Ph+ALL is induced and maintained by only one mutation. The fact that p96ABL/BCR is uniformly expressed in Ph+ALL strongly suggests an important role for this fusion protein in the initiation and maintenance of Ph+ ALL.
###end p 61
###begin p 62
###xml 234 242 234 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 314 321 314 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 468 475 468 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 468 475 468 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Huntly1">[32]</xref>
###xml 485 492 485 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 485 492 485 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 683 690 683 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 683 690 683 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 698 705 698 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 698 705 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 711 718 711 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 711 718 711 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 947 954 947 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 947 954 947 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1005 1012 1005 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1005 1012 1005 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1110 1117 1110 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1110 1117 1110 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1126 1133 1126 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 1126 1133 1126 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 1277 1281 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Wilson1">[33]</xref>
Herein, we provide the first evidence that t(9;22) does not give rise only to one, but to two leukemogenic fusion proteins, the BCR/ABL and ABL/BCR fusion proteins. Both ABL/BCR fusion proteins are able to induce a leukemic phenotype in vitro, as characterized by a block of differentiation and, in the case of p96ABL/BCR, of an increased replating efficiency of primitive HSCs under conditions that permit myeloid commitment. In contrast, as already reported for p210BCR/ABL[32], p185BCR/ABL was not able to block differentiation of myeloid precursors or increase replating efficiency. The lack of increased replating efficiency can be explained by the fact that, in contrast to p40ABL/BCR and p96ABL/BCR, p185BCR/ABL up-regulated Cdkn1a expression and did not up-regulate Wnt-signaling or HoxB4 expression. The up-regulation of Cdkn1a together with the down-regulation of c-Myc likely contributes to the maintenance of stem cell capacity by p185BCR/ABL. These findings suggest that the influence of p185BCR/ABL on primitive HSCs is characterized by the induction of a "dormant" or "silent" state, whereas p40ABL/BCR- and p96ABL/BCR induce proliferation of HSCs. Hence, we hypothesize that the t(9;22) fusion proteins are active at different levels of the stem cell hierarchy [33].
###end p 62
###begin p 63
###xml 18 25 18 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 33 40 33 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 232 239 232 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 232 239 232 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
Interestingly, p40ABL/BCR and p96ABL/BCR increased not only the stem cell capacity of primitive HSCs, but also exhibited leukemogenic potential, as shown in the transduction/transplantation model. The long latency, especially of p96ABL/BCR-positive leukemia, may be attributed to the need for additional mutations.
###end p 63
###begin p 64
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Whitehead1">[15]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Alberts1">[34]</xref>
###xml 254 261 254 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 254 261 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 269 276 269 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 448 455 448 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 475 482 475 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 475 482 475 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 534 541 534 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 534 541 534 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 722 723 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Previous data indicated that N-terminally truncated Rho-GEFs, such as NET1, may have oncogenic potential, mainly due to the presence of the Rho-GEF domain, which is defined by the DH- and PH-domains [15], [34]. Notwithstanding the differences between p40ABL/BCR and p96ABL/BCR regarding the presence of the putative oncogenic DH/PH domain, we have shown that both ABL/BCRs behave as hematopoietic oncogenes capable of inducing a leukemic phenotype in vivo. From our data, p96ABL/BCRseems to be the stronger oncogene as compared to p40ABL/BCR because of its capacity to increase the replating efficiency and stem cell capacity of primitive HSC. This characteristic might account for the aggressive biological behavior of Ph+ ALL compared to the initially indolent CP-CML.
###end p 64
###begin p 65
###xml 17 24 17 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 110 117 110 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Zheng1">[11]</xref>
The fact that p40ABL/BCR exhibits oncogenic potential may be attributed to its ability, which is shared by p96ABL/BCR, to activate Rac, a key player in the leukemogenesis of Ph+ leukemia. Furthermore, both ABL/BCRs inhibit Rho activation, which may contribute to the increase in stem cell capacity [11].
###end p 65
###begin p 66
###xml 502 509 502 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 502 509 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 516 523 516 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 516 523 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 934 938 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Griswold1">[35]</xref>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Beissert1">[36]</xref>
The activation of Rac is a common theme for ABL/BCR and BCR/ABL. This attribute may be the basis for the clinical relevance of the reciprocal t(9;22) fusion proteins, as they could maintain key signaling pathways, such as Rac signaling, upon effective inhibition of BCR/ABL kinase activity. In this way, the ABL/BCRs could play an important role in the grade of response to kinase inhibitors that target BCR/ABL. The capacity of ABL/BCR to autonomously induce leukemia suggests that the presence of p40ABL/BCR or p96ABL/BCR contributes to the maintenance of a leukemic subpopulation upon inhibition of BCR/ABL by ATP-analogues such as Imatinib, Dasatinib or Nilotinib, a scenario of particular importance in Ph+ ALL. One could speculate that the presence of ABL/BCR supports the proliferation of cells harboring BCR/ABL mutants with lower kinase activity, such as the T315I, which boasts nearly complete resistance to small molecules [35]-[36].
###end p 66
###begin p 67
###xml 32 39 32 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Yin1">[37]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-delaFuente1">[39]</xref>
###xml 356 363 356 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 356 363 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Kreil1">[40]</xref>
###xml 515 522 515 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 515 522 515 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 649 652 649 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Barnes2">[8]</xref>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
The clinical significance of p40ABL/BCR was addressed in several clinical studies that investigated the impact of the presence of der9 on clinical outcome; its significance is still controversially discussed [37]-[39]. A recent study on CML patients revealed that deletions of der9 spanning the ABL/BCR breakpoint, and thus abrogating the expression of p40ABL/BCR, were associated with an adverse prognosis [40]. Based on our data, one could speculate that these patients lacked the pro-proliferative effects of p40ABL/BCR at the stem cell level with a higher proportion of quiescent stem cells due to the up-regulation of Cdkn1a by BCR/ABL in HSCs [8].
###end p 67
###begin p 68
###xml 32 39 32 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 47 54 47 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 221 228 221 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 282 289 282 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 101 107 <span type="species:ncbi:10090">murine</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 293 299 <span type="species:ncbi:10090">murine</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 358 364 <span type="species:ncbi:10090">murine</span>
In contrast to the BCR/ABLs, p40ABL/BCR and p96ABL/BCR allow for myeloid and lymphatic commitment of murine HSCs. These data are confirmed by our findings on the B cell development of human UCBCs with the exception of p40ABL/BCRblocks it like BCR/ABL. These different effects of p40ABL/BCR on murine and human HSC may be due to differences between UCBCs and murine HSCs regarding their "maturation" state.
###end p 68
###begin p 69
###xml 38 45 38 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 54 61 54 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Cobaleda1">[24]</xref>
###xml 1254 1258 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Hagman1">[25]</xref>
###xml 1301 1308 1301 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 1301 1308 1301 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 1823 1826 1823 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1835 1839 1835 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Gonda1">[26]</xref>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
Based on our data presented here, p185BCR/ABL and p210BCR/ABL do not allow the commitment of HSCs to the lymphoid lineage because, in stem cell-derived B cell progenitors, both of these proteins down-regulate PAX5 and E2A. Expression of both PAX5 and E2A is essential for B cell lineage commitment. The critical contribution of PAX5 to lineage selection is illustrated by loss-of-function studies. In its absence, pro-B cells assume a multipotential phenotype and differentiate (under appropriate growth factor conditions) to T cells, NK cells, dendritic cells, macrophages, neutrophils or erythroid precursors. Conditional PAX5 deletion results in the retrodifferentiation of B cells to an uncommitted progenitor cell stage [24]. In addition, E2A expression is essential for B cell lineage commitment. Similar to B cell progenitors that lack Pax5, E2A-deficient cells reconstitute T cell, natural killer cell, myeloid, dendritic and erythroid lineages, but not B cells, following transfer into lethally irradiated mice. Interestingly, similar to the reported multipotency of B cell progenitors that lack Pax5, E2A-deficient cells possess stem-cell-like properties, including the expression of genes that are normally associated with non-B cell lineages [25]. Therefore, the "paradox" behavior of p185BCR/ABL-expressing HSCs upon mIL-7, mSCF, and Flt3-L influence, which is indicated by the expression of myeloid surface markers, may produce a scenario similar to a PAX5 or E2A deletion with a blockage of B cell commitment. The mechanism by which BCR/ABL down-regulates PAX5 and E2A is most likely related to up-regulation of ID2. ID2 likely has other effects in addition to its ability to down-regulate PAX5. It is known that the DNA-binding activity of PAX5 is decreased in ID2-overexpressing B cells and enhanced in ID2-/- B cells [26].
###end p 69
###begin p 70
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Klein1">[41]</xref>
BCR/ABL not only inhibits key factors involved in B cell commitment, but also interferes with pre-B cell receptor signaling by down-regulating key proteins whose deregulation causes a block of differentiation at an early pre-B or pro-B cell level. This was confirmed by recent findings that indirectly showed an effect of BCR/ABL on pre-B cell receptor signaling. More specifically, it was shown that, in Ph+ ALL cell lines, expression of the main pre-B cell receptor signaling components was restored upon exposure to Imatinib [41].
###end p 70
###begin p 71
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Heisterkamp1">[42]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Huettner1">[43]</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Etten1">[44]</xref>
###xml 620 625 <span type="species:ncbi:10090">mouse</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
The negative influence of BCR/ABL on B cell commitment strongly suggests that, for the determination of the Ph+ ALL phenotype, an additional mechanism that allows t(9;22)-positive precursors to engage in B cell commitment, or at least to maintain B cell characteristics, must be present. Together with the fact that 100% of M-BCR Ph+ALL cells expressed the reciprocal ABL/BCR fusion proteins, our observation that the ABL/BCRs at least partially reversed the effects of BCR/ABL on B cell commitment indicates that they are the first candidates for this role. This result is in apparent contradiction with the transgenic mouse models of BCR/ABL-positive ALL [42], [43]. In both models, additional mutations that substitute for the role of ABL/BCR can not be excluded. In fact, the expression of BCR/ABL alone was shown to mainly induce a CML-like disease in mice [44].
###end p 71
###begin p 72
###xml 212 219 212 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 212 219 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 240 247 240 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
Taken together, we show for the first time that t(9;22) gives rise to two fusion proteins with leukemogenic potential, BCR/ABL and ABL/BCR, and our data provide the first evidence that, in m-BCR-positive ALL, p96ABL/BCR cooperates with p185BCR/ABL in the determination of the leukemic phenotype.
###end p 72
###begin title 73
Materials and Methods
###end title 73
###begin title 74
Plasmids
###end title 74
###begin p 75
###xml 23 30 23 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 36 43 36 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCR/ABL</sup>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>BCR/ABL</sup></italic>
###xml 48 55 48 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 63 70 63 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABL/BCR</sup>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>ABL/BCR</sup></italic>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Zheng1">[11]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Huntly2">[38]</xref>
###xml 681 685 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Huntly2">[38]</xref>
All cDNAs encoding p185BCR/ABL, p210BCR/ABL, p40ABL/BCR and p96ABL/BCR were described previously [11], [38]. All retroviral expression vectors used in this study were based on the bi-cistronic vectors PINCO or PAULO, with or without an internal ribosomal entry site (IRES) to drive translation of the two transgenes. PINCO and PAULO were converted into Gateway(R)-destination vectors by the introduction of a Gateway(R) cassette according to the manufacturer's instructions (Invitrogen, Karlsruhe, Germany). All related inserts were available in the Gateway(R) entry-vector (pENTR1A) for recombination into the destination vectors by using the "LR-clonase" enzyme kit (Invitrogen) [38].
###end p 75
###begin title 76
Cell Lines, Cell Culture, Transfection and Western Blotting
###end title 76
###begin p 77
All cell lines were obtained by the German Collection of Microorganisms and Cell Cultures (DSMZ). BV173, SD-1 and U937 cells were maintained in RPMI 1640 supplemented with 10% FCS (Invitrogen). TOM-1 cells were maintained in Iscove's Medium supplemented with 10% FCS and SupB15 in RPMI 1640 supplemented with 15% FCS. U937 cells were transduced with transgenes by electroporation using the Nucleofection technology according to the manufacturer's instructions (Amaxa, Heidelberg, Germany). The ecotropic Phoenix packaging cells were cultured in Dulbecco's modified Eagle medium (DMEM; Invitrogen) supplemented with 10% FCS and were transfected by the calcium-phosphate precipitation method according to widely established protocols.
###end p 77
###begin p 78
Western blot analyses were performed according to widely established protocols. The following antibodies were used: anti-ABL (alpha-ABL) (St. Cruz Biotechnology, Santa Cruz, CA, USA) and anti-BCR (alpha-BCR)(St. Cruz Biotechnology). Blocking and antibody incubation were performed in 5% low-fat dry milk, followed by washing in Tris-buffered saline (TBS) (10 mM Tris-HCl pH 8, 150 mM NaCl) containing 0.1% Tween20 (TBS-T).
###end p 78
###begin title 79
Topflash/Fopflash transactivation
###end title 79
###begin p 80
###xml 518 525 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
The reporter constructs pRT-LK, pGL3-OT and pGL3-OF were electroporated by nucleofection into U937 cells together with isomolar quantities of the pCDNA3 expression vector encoding the transgenes of interest. After 24-36 h, luciferase activity was determined using the Dual-Luciferase Reporter Assay System according to the manufacturer's instructions (Promega, Mannheim, Germany). Luciferase activity was normalized using a co-transfected construct that encodes Renilla luciferase under the control of a PGK-promoter. Results are given as the ratio between Topflash and Fopflash luciferase activity.
###end p 80
###begin title 81
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient samples and umbilical cord blood cells (UCBC)
###end title 81
###begin p 82
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Bug1">[45]</xref>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 414 419 <span type="species:ncbi:9606">Human</span>
###xml 611 616 <span type="species:ncbi:9606">Human</span>
Samples of mononuclear BM cells were obtained from patients with CML blast crisis or Ph+ ALL at first diagnosis and were frozen after informed and written consent with the approval of the ethics committee of the Goethe-University of Frankfurt. Immediately after thawing, the cells were lysed in Laemmli buffer and submitted to Western blot analysis.consecutive transduction rounds, every 8 to 12 hours, were done. Human umbilical cord blood was kindly provided by the Cord Blood Bank subdivision of the New York Blood Bank from healthy full-term pregnancies with the approval of the institutional review board. Human CD34+ cells were selected and CD34+ UCBC were enriched by immunomagnetic selection as described previously [45] and pre-stimulated for 48 hours in Quality Biological serum-free (QBSF)-60 medium (Quality Biological, Gaithersburg, MD) supplemented with c-Kit ligand (100 ng/ml; Kirin, Gunma, Japan), Flt3 ligand (100 ng/lL; Imclone Systems, New York, NY) and thrombopoietin (100 ng/ml; Kirin) prior to use.
###end p 82
###begin title 83
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Isolation of Sca1+/lin- HSCs
###end title 83
###begin p 84
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 140 141 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 533 534 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Sca1+/lin- HSCs were isolated from 8 to 12-week-old female C57BL/6N mice (Harlan Winkelmann GmbH, Borchen Germany) after euthanization by CO2-asphyxiation. BM was harvested from the femura and tibiae by flushing the bones with a syringe and 26-gauge needle. The cells were "lineage depleted" by labeling the cells with biotin-conjugated lineage panel antibodies against B220, CD3epsilon, Gr-1, Mac-1 and Ter-119 (BD/Pharmingen, San Diego, CA). Labeled cells were removed using streptavidin loaded "MACS" cell separation columns. Sca1+ cells were purified by immunomagnetic beads using the "MACS" cell separation columns according to the manufacturer's instructions (Myltenyi, Bergisch-Gladbach, Germany). Prior to further use, the purified cells were pre-stimulated for 2 days in medium containing either mIL-3 (20 ng/mL), mIL-6 (20 ng/mL) and mSCF (100 ng/mL) (Cell Concepts, Umkirch, Germany) for myeloid commitment or mIL-7 (20 ng/mL), Flt3-L (20 ng/mL) and mSCF (100 ng/mL) for lymphatic commitment.
###end p 84
###begin title 85
Retroviral infection
###end title 85
###begin p 86
Ecotropic Phoenix packaging cells were transfected with retroviral vectors as described before. Retroviral supernatant was collected at days 2 and 3 after transfection. Target cells were plated onto retronectin-coated (Takara-Shuzo, Shiga, Japan) non-tissue culture-treated 24-well-plates and exposed to the retroviral supernatant for 3 hours at 37degreesC in the presence of 4 microg/mL polybrene (Sigma, Steinheim, Germany). Cells were centrifuged at 2.200 rpm for 45 min. The infection was repeated 4 times and the minimal accepted infection efficiency was 70%, as assessed by the detection of GFP positive cells by Fluorescence-Activated Cell Sorting (FACS). Differences in the infection efficiency between samples did not exceed 10%.
###end p 86
###begin p 87
###xml 774 775 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 47 73 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
For the retroviral transduction of human UCBC, vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped retrovirus was generated by transiently transfecting H29 cells with 10 ug of vector DNA by calcium phosphate precipitation. After 72 hours, the H29 supernatant was used for cross-transduction of PG13 packaging cells in the presence of polybrene (8 ug/mL; Sigma, St. Louis, MO). High-titer retrovirus-producing PG13 subclones were selected by cell sorting for high EGFP expression. Retrovirus-containing supernatants were harvested from PG13 clones incubated in QBSF for 8 to 12 h, supplemented with 100 ng/ml of c-Kit ligand, Flt3 ligand, thrombopoietin and 4 ug/ml polybrene, filtered through a 0.45-Am filter (Costar, Acton, MA), and applied immediately to the CD34+ cells on retronectin-coated six-well plates (Takara). Three consecutive rounds of transduction were performed.
###end p 87
###begin title 88
Cell cycle analysis
###end title 88
###begin p 89
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Sca1+/lin- cells were collected from the cultures at 2 days post-infection, washed in PBS and fixed with 70% ethanol at -20degreesC. The cells were re-suspended in PBS containing propidium iodide (PI)(50 ug/ml) and RNAse (5 ug/ml) (Sigma, Steinheim, Germany) and incubated at 37degreesC for 30 min. The cells were immediately evaluated by FACS.
###end p 89
###begin title 90
Colony assays for determination of the colony forming cell (CFC) number and replating efficiency
###end title 90
###begin p 91
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 560 561 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
At day 5 post-infection, Sca1+/lin- cells were plated at 5x103 cells/mL in methyl-cellulose supplemented with either mIL-3 (20 ng/mL), mIL-6 (20 ng/mL) and mSCF (100 ng/mL) for myeloid commitment or mIL-7 (20 ng/mL), Flt3-L (20 ng/mL) and mSCF (100 ng/mL) for lymphatic commitment (StemCell Technologies, Vancouver, Canada). On day 10 after plating, the number of colony forming units (CFU) was determined. After washing out from the methyl-cellulose, the cells were stained with specific antibodies for the detection of surface marker expression by FACS. 5x103 cells/plate were replated in methyl-cellulose, thus permitting determination of the serial replating potency. Differentiation was assessed by the expression of c-Kit, Sca1, Gr-1 and Mac-1 (BD/Pharmingen) by FACS.
###end p 91
###begin title 92
Competitive re-population assay (CRA)
###end title 92
###begin p 93
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 412 413 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 464 465 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
All animals studies were conducted in accordance with national animal protection laws and were approved by the Institutional Review Board (Regierungsprasidium Darmstadt - F 39/06). The CRA was based on the CD45.1 - CD45.2 chimerism of C57BL/6N mice as described previously (Bug et al., 2004). Two days after retroviral infection, 104 CD45.1+/Sca1+/lin- cells were injected into lethally (11 Gy) irradiated CD45.2+ female recipients together with 5x104 normal Ly5.2+ BM cells. The portion of CD45.1+ donor cell-derived hematopoietic cells was determined by FACS analysis of cells after 12 weeks on BM - MNC. The cells were stained with conjugated monoclonal antibodies specific for CD45.1 and CD45.2 or with the mouse IgG2a isotype control (BD/Pharmingen).
###end p 93
###begin title 94
Transduction/transplantation model of leukemia
###end title 94
###begin p 95
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
Female C57BL/6N mice that were 8-12 weeks of age (Harlan Winckelmann, Borchen, Germany) were used as recipients and donors. Sca1+/lin- were isolated as described above. Recipients were sub-lethally irradiated with 8.5 Gy. 5x104 transduced Sca1+/lin- were inoculated into anesthetized mice by retro-orbital injection. The mice were sacrificed at the first appearance of morbidity, loss of weight (>10%), neurological abnormalities, failure to thrive or diarrhea. Statistical relevance was determined by the Log-rank test. The isolation of BM cells was performed as described above. Spleen cells were isolated by passing the tissue through a 40 microM Nylon cell strainer (Beckton-Dickinson, Le Pont de Claix, France). Whole BM and spleen cells were then cytospun on glass slides and stained with May-Grunwald-Giemsa. For surface marker analysis, the MNC were enriched on a Ficoll density gradient. Statistical relevance was determined by the Log-rank test.
###end p 95
###begin title 96
UCBC-derived B-lymphocytes
###end title 96
###begin p 97
###xml 26 27 26 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007661-Ohkawara1">[23]</xref>
For B cell induction, 2x104 transduced CD34+ cells were plated on MS-5 cells in MEM alpha supplemented with 10% FCS, 0.1 mM monothiolglycerol, 2 mM glutamine, 10 ng/ml huSCF and 5 ng/ml huG-CSF and were demi-depopulated on a weekly basis [23]. After three weeks, the suspension cells were harvested for further analysis.
###end p 97
###begin title 98
Quantitative real time PCR (qRT-PCR) - Taqmantrade mark
###end title 98
###begin p 99
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 770 782 761 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;/&#916;</sup>
Total RNA and first strand cDNA were obtained from Sca1+/lin- HSCs according to standard protocols. The TaqMantrade mark PCR was conducted in duplicate following standard protocols using the ABI PRISM 7700 (Applied Biosystems, Darmstadt, Germany). For the quantification of mRNA, gene expression quantification using "Assay-on-demand" for Cdkn1a, HoxB4, c-Myc, SCL, PAX5, E2A, ID2, BLNK, CD79 and D19 was performed according to the manufacturer's instructions (Applied Biosystems). Normalization to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was done for each sample. CT values were exported into a Microsoft Excel worksheet for calculation of fold changes according to the Comparative CT method. The amount of target, normalized to endogenous GAPDH, is given by 2-Delta/Delta CT.
###end p 99
###begin title 100
References
###end title 100
###begin article-title 101
The biology of chronic myeloid leukemia.
###end article-title 101
###begin article-title 102
###xml 61 66 <span type="species:ncbi:9606">human</span>
Chronic myeloid leukaemia as a model of disease evolution in human cancer.
###end article-title 102
###begin article-title 103
The Biology of CML Blast Crisis.
###end article-title 103
###begin article-title 104
Treatment of adult acute lymphoblastic leukemia.
###end article-title 104
###begin article-title 105
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
###end article-title 105
###begin article-title 106
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia.
###end article-title 106
###begin article-title 107
Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia.
###end article-title 107
###begin article-title 108
Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia.
###end article-title 108
###begin article-title 109
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.
###end article-title 109
###begin article-title 110
The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants.
###end article-title 110
###begin article-title 111
BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility.
###end article-title 111
###begin article-title 112
The Bcr kinase down-regulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.
###end article-title 112
###begin article-title 113
Bcr interferes with beta-catenin-Tcf1 interaction.
###end article-title 113
###begin article-title 114
Rho GTPases and signaling networks.
###end article-title 114
###begin article-title 115
Dbl family proteins.
###end article-title 115
###begin article-title 116
Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.
###end article-title 116
###begin article-title 117
Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
###end article-title 117
###begin article-title 118
Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
###end article-title 118
###begin article-title 119
Hematopoiesis: an evolving paradigm for stem cell biology.
###end article-title 119
###begin article-title 120
Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.
###end article-title 120
###begin article-title 121
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.
###end article-title 121
###begin article-title 122
Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
###end article-title 122
###begin article-title 123
###xml 62 67 <span type="species:ncbi:9606">human</span>
Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors.
###end article-title 123
###begin article-title 124
Pax5: the guardian of B cell identity and function.
###end article-title 124
###begin article-title 125
Transcription factors drive B cell development.
###end article-title 125
###begin article-title 126
The balance between Pax5 and Id2 activities is the key to AID gene expression.
###end article-title 126
###begin article-title 127
Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
###end article-title 127
###begin article-title 128
Cell signaling and tumorigenesis.
###end article-title 128
###begin article-title 129
BLNK: a central linker protein in B cell activation.
###end article-title 129
###begin article-title 130
The age incidence of chronic myeloid leukemia can be explained by a one-mutation model.
###end article-title 130
###begin article-title 131
Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate.
###end article-title 131
###begin article-title 132
###xml 81 87 <span type="species:ncbi:10090">murine</span>
MOZ-TIF2, but not BCR-ABL confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
###end article-title 132
###begin article-title 133
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation.
###end article-title 133
###begin article-title 134
Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.
###end article-title 134
###begin article-title 135
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.
###end article-title 135
###begin article-title 136
Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL.
###end article-title 136
###begin article-title 137
Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study.
###end article-title 137
###begin article-title 138
Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.
###end article-title 138
###begin article-title 139
ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia.
###end article-title 139
###begin article-title 140
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia.
###end article-title 140
###begin article-title 141
The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
###end article-title 141
###begin article-title 142
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
Acute leukaemia in bcr/abl transgenic mice.
###end article-title 142
###begin article-title 143
Reversibility of acute B-cell leukaemia induced by BCR-ABL1.
###end article-title 143
###begin article-title 144
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Studying the pathogenesis of BCR-ABL+ leukemia in mice.
###end article-title 144
###begin article-title 145
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
###end article-title 145
###begin p 146
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 146
###begin p 147
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by grants from Deutsche Krebshilfe e.V. to Martin Ruthardt (107063) and to Reinhard Henschler (107068) in the joint project 'Pathologische Genprodukte und ihre Wirkmechanismen' (102362). Xiaomin Zheng was supported by a fellowship from German Jose Carreras Leukemia-Foundation (DJCLS- F04/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M.R. is further funded by grants from German Jose Carreras Leukemia-Foundation (DJCLS - R 07/27f), Deutsche Forschungsgemeinschaft (DFG-RU 728/3-1), Deutsche Krebshilfe e.V. (DKH-107741), and Alfred und Angelika Gutermuth Foundation.
###end p 147

